Congress has consistently failed to solve some serious problems with the cost, effectiveness, and safety of pharmaceuticals. In part, this failure results from the pharmaceutical industry convincing legislators to define policy problems in ways that protect industry profits. By targeting campaign contributions to influential legislators and by providing them with selective information, the industry manages to displace the public’s voice in developing pharmaceutical policy.
Jorgensen, P. (2013). Pharmaceuticals, Political Money, and Public Policy: A Theoretical and Empirical Agenda. Journal of Law, Medicine & Ethics, 41(3), 561-570. doi:10.1111/jlme.12065
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.
Journal of Law, Medicine & Ethics